Ascorbic Acid to Prevent Postreperfusion Syndrome in Liver Transplantation

NCT05754242 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Postreperfusion Syndrome
Ascorbic Acid

Interventions

DRUG: Ascorbic acid
DRUG: 0.9% Saline solution

Sponsor

Hospital Universitario Ramon y Cajal